When dividing SLE patients into patients with a low proportion of Treg cells and patients with a high proportion of Treg cells, SLE patients with a low proportion of Tregs had higher probability of achieving GR to IL-2 treatment at the 12th week. This evidence concerns the gene IL2 and systemic lupus erythematosus.